drugset / Trial / NCT02840799

Effect of KNO3 Compared to KCl on Oxygen UpTake in Heart Failure With Preserved Ejection Fraction (KNO3CK OUT HFPEF)

NCT02840799

RandomizedCrossoverQuadruple-blindTreatment

Summary

This trial seeks to assess if potassium nitrate (KNO3) therapy improves exercise capacity and oxygen uptake in heart failure patients with preserved ejection fraction (HFpEF).

Timeline

Start
2016-08
Primary completion
2022-08
Completion
2022-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Potassium Nitrate Other / unclassified 6 mmol

Indications